These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21288848)

  • 21. Viral load in patients infected with pandemic H1N1 2009 influenza A virus.
    To KK; Chan KH; Li IW; Tsang TY; Tse H; Chan JF; Hung IF; Lai ST; Leung CW; Kwan YW; Lau YL; Ng TK; Cheng VC; Peiris JS; Yuen KY
    J Med Virol; 2010 Jan; 82(1):1-7. PubMed ID: 19950247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
    Maier HE; Nachbagauer R; Kuan G; Ng S; Lopez R; Sanchez N; Stadlbauer D; Gresh L; Schiller A; Rajabhathor A; Ojeda S; Guglia AF; Amanat F; Balmaseda A; Krammer F; Gordon A
    Clin Infect Dis; 2020 May; 70(11):2290-2297. PubMed ID: 31300819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
    Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza.
    Jia N; Gao Y; Suo JJ; Xie LJ; Yan ZQ; Xing YB; He L; Liu YX
    Chin Med J (Engl); 2011 May; 124(10):1576-9. PubMed ID: 21740820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.
    Crum-Cianflone NF; Eberly LE; Duplessis C; Maguire J; Ganesan A; Faix D; Defang G; Bai Y; Iverson E; Lalani T; Whitman T; Blair PJ; Brandt C; Macalino G; Burgess T
    Clin Infect Dis; 2011 Jan; 52(1):138-46. PubMed ID: 21148532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection.
    Neuzil KM; Coffey CS; Mitchel EF; Griffin MR
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):304-7. PubMed ID: 14600576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients.
    Rahamat-Langendoen JC; Tutuhatunewa ED; Schölvinck EH; Hak E; Koopmans M; Niesters HG; Riezebos-Brilman A
    J Clin Virol; 2012 Jun; 54(2):135-40. PubMed ID: 22398034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals.
    Kok J; Tudo K; Blyth CC; Foo H; Hueston L; Dwyer DE
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):91-4. PubMed ID: 21084991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections.
    Ip DKM; Lau LLH; Chan KH; Fang VJ; Leung GM; Peiris MJS; Cowling BJ
    Clin Infect Dis; 2016 Feb; 62(4):431-437. PubMed ID: 26518469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.
    Lehners N; Tabatabai J; Prifert C; Wedde M; Puthenparambil J; Weissbrich B; Biere B; Schweiger B; Egerer G; Schnitzler P
    PLoS One; 2016; 11(2):e0148258. PubMed ID: 26866481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses.
    Esposito S; Molteni CG; Daleno C; Tagliabue C; Picciolli I; Scala A; Pelucchi C; Fossali E; Principi N
    J Infect; 2011 Oct; 63(4):300-7. PubMed ID: 21839113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract.
    Chan MC; Chan RW; Yu WC; Ho CC; Yuen KM; Fong JH; Tang LL; Lai WW; Lo AC; Chui WH; Sihoe AD; Kwong DL; Wong DS; Tsao GS; Poon LL; Guan Y; Nicholls JM; Peiris JS
    Am J Pathol; 2010 Apr; 176(4):1828-40. PubMed ID: 20110407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period.
    Matos AR; Martins JSCC; Oliveira MLA; Garcia CC; Siqueira MM
    Infect Genet Evol; 2019 Jan; 67():55-59. PubMed ID: 30389547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy.
    Fabbiani M; Sali M; Di Cristo V; Pignataro G; Prete V; Farina S; D'Avino A; Manzara S; Dal Verme LZ; Silveri NG; Cauda R; Delogu G; Fadda G; Di Giambenedetto S
    J Med Virol; 2011 Dec; 83(12):2057-65. PubMed ID: 22012711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection.
    Madhi SA; Ramasamy N; Bessellar TG; Saloojee H; Klugman KP
    Pediatr Infect Dis J; 2002 Apr; 21(4):291-7. PubMed ID: 12075759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients.
    Choi SM; Xie H; Campbell AP; Kuypers J; Leisenring W; Boudreault AA; Englund JA; Corey L; Boeckh M
    J Infect Dis; 2012 Dec; 206(12):1872-7. PubMed ID: 23033148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua.
    Gordon A; Saborío S; Videa E; López R; Kuan G; Balmaseda A; Harris E
    Clin Infect Dis; 2010 Jun; 50(11):1462-7. PubMed ID: 20420502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).
    Fraaij PL; Schutten M; Javouhey E; Burleigh L; Outlaw R; Kumar D; Boucher CA
    Antivir Ther; 2015; 20(6):633-42. PubMed ID: 25849228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.